Price T Rowe Associates Inc Entrada Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,567,478 shares of TRDA stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,567,478

Previous 2,736,767 6.19%

Holding current value

$13.2 Million

Previous $24.7 Million 30.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.72 - $9.23 $1.14 Million - $1.56 Million	-169,289 Reduced 6.19%	2,567,478 $17.3 Million
Q1 2025 May 14, 2025	SELL	$9.04 - $18.31 $1.5 Million - $3.04 Million	-166,258 Reduced 5.73%	2,736,767 $24.7 Million
Q4 2024 Feb 14, 2025	SELL	$15.82 - $21.59 $2.32 Million - $3.16 Million	-146,547 Reduced 4.81%	2,903,025 $50.2 Million
Q3 2024 Nov 14, 2024	SELL	$13.65 - $17.86 $1.16 Million - $1.52 Million	-84,886 Reduced 2.71%	3,049,572 $48.7 Million
Q2 2024 Aug 14, 2024	BUY	$11.85 - $16.45 $4.52 Million - $6.27 Million	381,101 Added 13.84%	3,134,458 $44.7 Million
Q1 2024 May 15, 2024	SELL	$11.58 - $17.0 $2.97 Million - $4.36 Million	-256,316 Reduced 8.52%	2,753,357 $39 Million
Q4 2023 Feb 14, 2024	BUY	$11.36 - $16.99 $109,464 - $163,715	9,636 Added 0.32%	3,009,673 $45.4 Million
Q3 2023 Nov 14, 2023	BUY	$13.61 - $18.01 $840,131 - $1.11 Million	61,729 Added 2.1%	3,000,037 $47.4 Million
Q2 2023 Aug 14, 2023	SELL	$11.02 - $18.01 $502,016 - $820,445	-45,555 Reduced 1.53%	2,938,308 $44.5 Million
Q1 2023 May 15, 2023	SELL	$9.58 - $16.2 $292,324 - $494,326	-30,514 Reduced 1.01%	2,983,863 $43.3 Million
Q4 2022 Feb 14, 2023	BUY	$13.52 - $22.89 $572,261 - $968,865	42,327 Added 1.42%	3,014,377 $40.8 Million
Q3 2022 Nov 14, 2022	BUY	$9.65 - $15.76 $5.16 Million - $8.42 Million	534,552 Added 21.93%	2,972,050 $46.8 Million
Q2 2022 Aug 15, 2022	SELL	$5.49 - $12.94 $314,115 - $740,375	-57,216 Reduced 2.29%	2,437,498 $29.7 Million
Q1 2022 May 16, 2022	BUY	$7.99 - $16.93 $3.79 Million - $8.03 Million	474,077 Added 23.46%	2,494,714 $23.4 Million
Q4 2021 Feb 14, 2022	BUY	$13.7 - $35.0 $27.7 Million - $70.7 Million	2,020,637 New	2,020,637 $34.6 Million

Others Institutions Holding TRDA

# of Institutions

107

Shares Held

28.8M

Call Options Held

15.7K

Put Options Held

View Full List

About Entrada Therapeutics, Inc.

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $162M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

More about TRDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Entrada Therapeutics, Inc. Transaction History